BRAINBox Solutions to Present Groundbreaking Concussion Testing Data
BRAINBox Solutions, a leader in advanced diagnostics for concussive injuries, is set to unveil their latest findings on multimodal concussion diagnostic and prognostic testing during the upcoming Emergencies in Medicine Conference in Maui, scheduled from December 6 to 9, 2026. This presentation will highlight data obtained from the ongoing HeadSMART clinical trials, focusing specifically on geriatric and young adult patient populations.
Highlighting the Importance of Multimodal Testing
Concussions, commonly referred to as mild traumatic brain injuries (mTBI), pose significant challenges in both diagnosis and treatment. Traditional assessment tools often depend on qualitative methods, which can lead to inconsistent results, particularly in diverse age groups such as adolescents and the elderly.
W. Franklin Peacock MD, the Principal Investigator from Baylor College of Medicine, expressed the ongoing challenges professionals face when assessing these injuries. He noted that the reliance on subjective measures complicates both diagnosis and long-term risk assessments in affected individuals. Dr. Peacock emphasized the need for a more objective testing approach that can reliably serve various patient demographics including those involved in sports and older adults suffering from falls or other incidents.
he data presented in Maui is pivotal, as it arises from two crucial studies: one focused on sports-related concussions in younger adults, and another exploring the use of routine head CT imaging in older adults with traumatic brain injuries.
Sports-Related Concussions in Young Adults
The research regarding sports-related injuries aims to develop an objective, AI-driven test that integrates blood biomarkers and neurocognitive assessments. By focusing on a specific age group (ages 18-20), the study sought to determine whether previous models applied to adults aged 21-50 could be effectively generalized to younger athletes.
Findings revealed that a panel of three biomarkers—ST2, GFAP, and NRGN—paired with cognitive testing using BrainCheck® could differentiate mTBI- from mTBI+ cases, including among adolescent athletes. This significant advancement could transform how sports injuries are addressed on the field and in clinical settings, shifting from judgment-based evaluations towards more factual, data-driven conclusions.
Risk Stratification in Older Adults
Alongside the younger demographic, the second study examined the potential for existing CT imaging protocols combined with biomarker analysis to stratify risk among older adults suffering from mTBI. Traditionally, CT scans offer qualitative evaluations of brain health, but BRAINBox's innovative approach allows the quantification of brain volume and specific atrophy patterns that are often missed in standard assessments.
Through their proprietary algorithm, researchers successfully evaluated brain volumetrics from standard CT scans to identify distinct patterns of atrophy—like those associated with Alzheimer's or vascular issues. Alarmingly, they found 15% of participants exhibited severe, convergent atrophy alongside cognitive decline, signaling a particularly high-risk subgroup that could benefit from targeted rehabilitation strategies.
This research lays the groundwork for creating a more nuanced understanding of brain health post-injury, with hopes that it could lead to improved monitoring and tailored recovery programs within a two-week window from injury.
Looking Ahead
BRAINBox Solutions is dedicated to revolutionizing the way concussions and related injuries are understood and treated. The company is on a path to establish a new benchmark for clinical best practices surrounding concussion diagnostics. Their innovative approach integrates blood biomarkers, rapid assessment tools, and cognitive tests into a cohesive TBI injury score, an advancement that could potentially reframe responses to head injuries across various demographics.
As the presentation date at the Emergencies in Medicine Conference approaches, CEO Donna Edmonds conveyed confidence in the significance of these findings. She stressed the objective of keeping health care stakeholders updated on their advances and the transformative potential for consistent concussion testing across age groups. BRAINBox aims to capitalize on these ongoing studies to ensure accuracy, reliability, and improved patient outcomes moving forward.
To learn more about BRAINBox Solutions and their initiatives, visit
www.brainboxinc.com.